Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

MDS 2022 | Biofeedback-based treatments for functional tremor

Alberto Espay, MD, MSc, University of Cincinnati, Cincinnati, OH, outlines promising therapeutic options under evaluation for the treatment of functional tremor, the most common functional movement disorder. Entrainment, the change or elimination of tremor as patients perform a voluntary rhythmical movement by the unaffected limb, is a critical diagnostic hallmark of functional tremor that is now used as a bedside therapeutic biofeedback strategy in some patients. The implementation of biofeedback-based treatment protocols can lead to tremor freedom and empower the patients. This interview took place at the 2022 International Congress of Parkinson’s Disease and Movement Disorders in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Disclosures

Prof. Espay has received grant support from the NIH and the Michael J Fox Foundation; personal compensation as a consultant/scientific advisory board member for Abbvie, Neuroderm, Neurocrine, Amneal, Acadia, Acorda, Kyowa Kirin, Sunovion, Lundbeck, and USWorldMeds; honoraria from Acadia, Sunovion, Amneal, USWorldMeds; and publishing royalties from Lippincott Williams & Wilkins, Cambridge University Press, and Springer. He cofounded REGAIN Therapeutics, owner of a patent application that covers synthetic soluble non-aggregating peptide analogs as a replacement treatment in proteinopathies. He serves on the editorial boards of the Journal of Parkinson’s Disease, Journal of Alzheimer’s Disease, European Journal of Neurology, and JAMA Neurology.